相似文献
1
Bivalent diketopiperazine-based tropomysin receptor kinase C (TrkC) antagonists.
J Med Chem. 2010 Jul 8;53(13):5044-8. doi: 10.1021/jm100148d.
2
Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals.
ACS Chem Biol. 2009 Sep 18;4(9):769-81. doi: 10.1021/cb9001415.
3
A peptidomimetic of NT-3 acts as a TrkC antagonist.
Peptides. 2009 Oct;30(10):1833-9. doi: 10.1016/j.peptides.2009.07.015. Epub 2009 Jul 30.
4
Combinatorial assembly of small molecules into bivalent antagonists of TrkC or TrkA receptors.
PLoS One. 2014 Mar 6;9(3):e89617. doi: 10.1371/journal.pone.0089617. eCollection 2014.
5
Neurotrophin-3 Regulates Synapse Development by Modulating TrkC-PTPσ Synaptic Adhesion and Intracellular Signaling Pathways.
J Neurosci. 2016 Apr 27;36(17):4816-31. doi: 10.1523/JNEUROSCI.4024-15.2016.
6
Downstream of tyrosine kinase/docking protein 6, as a novel substrate of tropomyosin-related kinase C receptor, is involved in neurotrophin 3-mediated neurite outgrowth in mouse cortex neurons.
BMC Biol. 2010 Jun 18;8:86. doi: 10.1186/1741-7007-8-86.
7
[The role of TrkC receptor and neurotrophin 3 in the development and function of neural cells].
Postepy Hig Med Dosw (Online). 2005;59:517-22.
8
Neurotrophin-3 Enhances the Synaptic Organizing Function of TrkC-Protein Tyrosine Phosphatase σ in Rat Hippocampal Neurons.
J Neurosci. 2015 Sep 9;35(36):12425-31. doi: 10.1523/JNEUROSCI.1330-15.2015.
9
Neurodevelopment. Dendrite morphogenesis depends on relative levels of NT-3/TrkC signaling.
Science. 2014 Oct 31;346(6209):626-9. doi: 10.1126/science.1258996.
10
New templates for syntheses of ring-fused, C(10) beta-turn peptidomimetics leading to the first reported small-molecule mimic of neurotrophin-3.
J Med Chem. 2002 Sep 26;45(20):4387-90. doi: 10.1021/jm0255421.
引用本文的文献
1
Selective Modulation of Trk Receptors by -Organopeptides.
ACS Chem Neurosci. 2025 Aug 6;16(15):2776-2784. doi: 10.1021/acschemneuro.4c00833. Epub 2025 Jul 9.
2
Selective inhibitors of the TrkC.T1 receptor reduce retinal inflammation and delay neuronal death in a model of retinitis pigmentosa.
PNAS Nexus. 2025 Feb 4;4(2):pgaf020. doi: 10.1093/pnasnexus/pgaf020. eCollection 2025 Feb.
3
Selective, Intrinsically Fluorescent Trk Modulating Probes.
ACS Chem Neurosci. 2024 Oct 2;15(20):3679-91. doi: 10.1021/acschemneuro.4c00290.
4
Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold.
Biomolecules. 2021 Oct 14;11(10):1515. doi: 10.3390/biom11101515.
5
Neuroprotection: Pro-survival and Anti-neurotoxic Mechanisms as Therapeutic Strategies in Neurodegeneration.
Front Cell Neurosci. 2019 Jun 6;13:231. doi: 10.3389/fncel.2019.00231. eCollection 2019.
6
Microwave-assisted facile construction of quinoxalinone and benzimidazopyrazinone derivatives via two paths of post-Ugi cascade reaction.
Mol Divers. 2019 Feb;23(1):137-145. doi: 10.1007/s11030-018-9855-y. Epub 2018 Aug 2.
7
Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.
J Alzheimers Dis. 2017;55(1):391-410. doi: 10.3233/JAD-160051.
8
Targeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT).
Mol Pharm. 2015 Jan 5;12(1):212-22. doi: 10.1021/mp5005564. Epub 2014 Dec 9.
9
Combinatorial assembly of small molecules into bivalent antagonists of TrkC or TrkA receptors.
PLoS One. 2014 Mar 6;9(3):e89617. doi: 10.1371/journal.pone.0089617. eCollection 2014.
10
Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.
J Med Chem. 2013 Dec 12;56(23):9471-9481. doi: 10.1021/jm400794z. Epub 2013 Nov 21.
本文引用的文献
1
Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals.
ACS Chem Biol. 2009 Sep 18;4(9):769-81. doi: 10.1021/cb9001415.
2
A peptidomimetic of NT-3 acts as a TrkC antagonist.
Peptides. 2009 Oct;30(10):1833-9. doi: 10.1016/j.peptides.2009.07.015. Epub 2009 Jul 30.
3
The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors.
CNS Neurol Disord Drug Targets. 2008 Feb;7(1):46-62. doi: 10.2174/187152708783885174.
4
A combinatorial method for solution-phase synthesis of labeled bivalent beta-turn mimics.
J Am Chem Soc. 2008 Jan 16;130(2):556-65. doi: 10.1021/ja074717z. Epub 2007 Dec 19.
5
Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities.
Chem Biol. 2005 Sep;12(9):1015-28. doi: 10.1016/j.chembiol.2005.06.015.
6
Selective formation of homo- and heterobivalent peptidomimetics.
J Med Chem. 2003 Aug 14;46(17):3565-7. doi: 10.1021/jm034103e.
7
Small molecule Trk receptor agonists and other neurotrophic factor mimetics.
Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):59-80. doi: 10.2174/1568007023339490.
8
Design of potent peptide mimetics of brain-derived neurotrophic factor.
J Biol Chem. 2003 Jul 11;278(28):25738-44. doi: 10.1074/jbc.M303209200. Epub 2003 May 2.
9
New templates for syntheses of ring-fused, C(10) beta-turn peptidomimetics leading to the first reported small-molecule mimic of neurotrophin-3.
J Med Chem. 2002 Sep 26;45(20):4387-90. doi: 10.1021/jm0255421.
10
Entry to new conformationally constrained amino acids. First synthesis of 3-unsubstituted 4-alkyl-4-carboxy-2-azetidinone derivatives via an intramolecular N(alpha)-C(alpha)-cyclization strategy.
J Org Chem. 2001 May 18;66(10):3538-47. doi: 10.1021/jo015559b.
Zotero 插件